Afya Limited (NASDAQ:AFYA – Get Free Report) insider Santos Welder Ferreira sold 3,325 shares of the company’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $15.90, for a total value of $52,867.50. Following the completion of the sale, the insider owned 35,000 shares in the company, valued at approximately $556,500. This represents a 8.68% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Afya Price Performance
Shares of NASDAQ AFYA opened at $15.82 on Tuesday. The business’s 50 day moving average price is $14.54 and its 200 day moving average price is $14.68. The firm has a market cap of $1.48 billion, a P/E ratio of 10.84, a P/E/G ratio of 0.71 and a beta of 0.48. Afya Limited has a 52 week low of $13.00 and a 52 week high of $19.90. The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.41.
Afya (NASDAQ:AFYA – Get Free Report) last issued its earnings results on Wednesday, March 11th. The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.05. The firm had revenue of $147.08 million for the quarter, compared to analyst estimates of $174.74 million. Afya had a return on equity of 18.77% and a net margin of 20.31%. On average, sell-side analysts expect that Afya Limited will post 1.67 earnings per share for the current year.
Afya Dividend Announcement
Analyst Ratings Changes
AFYA has been the subject of a number of research reports. Zacks Research upgraded shares of Afya from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, April 7th. Bank of America cut Afya from a “buy” rating to a “neutral” rating and reduced their price target for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. UBS Group reiterated a “neutral” rating and set a $16.00 price target (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Finally, Sanford C. Bernstein upgraded Afya to a “market perform” rating in a research report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $17.30.
Read Our Latest Research Report on Afya
Hedge Funds Weigh In On Afya
A number of hedge funds have recently bought and sold shares of the business. XTX Topco Ltd purchased a new position in Afya during the fourth quarter worth approximately $215,000. Mangrove Partners IM LLC purchased a new position in Afya during the fourth quarter worth approximately $197,000. State Street Corp boosted its position in Afya by 25.8% during the fourth quarter. State Street Corp now owns 126,914 shares of the company’s stock worth $1,955,000 after purchasing an additional 26,005 shares in the last quarter. Campbell & CO Investment Adviser LLC boosted its position in Afya by 45.3% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company’s stock worth $612,000 after purchasing an additional 12,365 shares in the last quarter. Finally, Banco BTG Pactual S.A. purchased a new position in Afya during the fourth quarter worth approximately $462,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Recommended Stories
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
